-
MSI Reproductive Choices UK comment on the reclassification of the progestogen-only pill
Media statement London, 9th July 2021 If you are covering the reclassification of the progestogen-only pill, you may find the following statement from MSI Reproductive Choices UK helpful. Simphiwe Sesane contraceptive nurse and faculty registered trainer at …
-
MSI Reproductive Choices UK statement on fitting intrauterine contraception (IUC) and pain relief
London, 23rd June 2021 Following recent coverage on the fitting of intrauterine contraception (IUC) and concerns surrounding associated pain, Julia Hogan (MSI Reproductive Choices’ UK contraceptive and sexual health nurse consultant) comments. Statement on fitting intrauterine …
-
More than a third of UK women unsure how to access contraception during COVID-19
New data released ahead of World Contraception Day, reveals UK women’s needs have been neglected during the pandemic – with young women and girls worst affected London – Friday, 24th September 2020: More than a third …
-
Press release: 1.9m clients lost access to our services due to COVID-19
1.9M women and girls worldwide have lost access to our contraception and safe abortion services due to COVID-19 London – Wednesday, 19th August 2020: MSI reveals new data showing that 1.9 million[i] women and girls have lost …
-
Marie Stopes UK comment on ONS Conception Statistics
Media statement London, 4th March 2020 – Today’s ONS Statistics for England and Wales, show that: Marie Stopes UK’s Medical Director Jonathan Lord said: “Both the reduction in the conception rate and the 1.3% increase in the …
-
Marie Stopes UK comment on contraceptive shortages
Friday 7th February 2020: If you are covering today’s press release on contraceptive and hormone replacement therapy (HRT) shortages from The Royal College of Obstetricians and Gynaecologists, The British Menopause Society and The Faculty of Sexual and Reproductive Healthcare, …
